| Xenloxy vs Lidia | 93–92 | 50.27% |
| Xenloxy vs Kazuya | 74–47 | 61.16% |
| Xenloxy vs Bryan | 56–47 | 54.37% |
| Xenloxy vs Reina | 55–47 | 53.92% |
| Xenloxy vs Heihachi | 49–40 | 55.06% |
| Xenloxy vs Jin | 46–36 | 56.10% |
| Xenloxy vs Law | 33–39 | 45.83% |
| Xenloxy vs Dragunov | 30–32 | 48.39% |
| Xenloxy vs Yoshimitsu | 35–26 | 57.38% |
| Xenloxy vs King | 36–24 | 60.00% |
| Xenloxy vs Lars | 24–31 | 43.64% |
| Xenloxy vs Jun | 28–26 | 51.85% |
| Xenloxy vs Lee | 24–28 | 46.15% |
| Xenloxy vs Victor | 27–23 | 54.00% |
| Xenloxy vs Devil Jin | 29–19 | 60.42% |
| Xenloxy vs Steve | 26–17 | 60.47% |
| Xenloxy vs Azucena | 16–27 | 37.21% |
| Xenloxy vs Lili | 20–19 | 51.28% |
| Xenloxy vs Feng | 12–26 | 31.58% |
| Xenloxy vs Eddy | 12–26 | 31.58% |
| Xenloxy vs Paul | 12–25 | 32.43% |
| Xenloxy vs Nina | 21–15 | 58.33% |
| Xenloxy vs Raven | 21–14 | 60.00% |
| Xenloxy vs Asuka | 13–21 | 38.24% |
| Xenloxy vs Leroy | 11–21 | 34.38% |
| Xenloxy vs Xiaoyu | 17–12 | 58.62% |
| Xenloxy vs Hwoarang | 11–17 | 39.29% |
| Xenloxy vs Alisa | 11–16 | 40.74% |
| Xenloxy vs Shaheen | 12–11 | 52.17% |
| Xenloxy vs Jack-8 | 10–12 | 45.45% |
| Xenloxy vs Clive | 9–13 | 40.91% |
| Xenloxy vs Leo | 9–12 | 42.86% |
| Xenloxy vs Claudio | 7–9 | 43.75% |
| Xenloxy vs Zafina | 7–9 | 43.75% |
| Xenloxy vs Kuma | 7–4 | 63.64% |
| Xenloxy vs Panda | 4–3 | 57.14% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.